@FierceMedDev: BioFire Diagnostics wins FDA clearance for innovative GI panel. Article | Follow @FierceMedDev
@VarunSaxena2: Apple on medical tech hiring spree, a possible hint of iWatch plans. Story via Reuters | Follow @VarunSaxena2
@EmilyWFierce: New Dx machine from student at MIT uses magnets and lasers to quickly spot. More from the Boston Globe | Follow @EmilyWFierce
@MichaelGFierce: Oramed's oral insulin PhIIa details show a compromised study, and shares continue to fall. Story via FierceDrugDelivery | Follow @MichaelGFierce
> Amid the boom in e-cigarettes, a startup is working on a medical device designed to help smokers quit. Article
> Hemostatic outfit Z-Medica has signed a deal with Taureon to get its hands on Novacol, an anti-bleeding device. News
> Biosensors won the FDA's blessing to start a U.S. clinical trial of its BioFreedom drug-coated stent. Item
Biotech News
@FierceBiotech: Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO. Story | Follow @FierceBiotech
@JohnCFierce: Pfizer down more than 2% on some miserable Q1 numbers. Only more fuel for the M&A fire. | Follow @JohnCFierce
@DamianFierce: It's FDA decision day for epanova, the cardio drug AstraZeneca picked up in its $443M deal for Omthera. | Follow @DamianFierce
@EmilyMFierce: As MERS arrives in U.S., Novavax, UofMaryland report positive preclinical results for MERS vaccine. Story via FierceBiotech Research | Follow @EmilyMFierce
> Global R&D centers brace for another blow as Pfizer circles AstraZeneca. More
> Novartis' long-acting Signifor passes PhIII test for acromegaly. Story
> Regeneron jumps into next-gen gene therapy tech with $640M eye drug deal. Article
Pharma News
@FiercePharma: Pfizer's 'weak' Q1 numbers bolster case for AZ buy--and post-merger split, too. More | Follow @FiercePharma
@TracyStaton: Forest founder, CEO set for $100M-plus yield from Actavis buyout. Article | Follow @TracyStaton
@EricPFierce: With all of the deals going on, Teva CEO thinks a buy in biosimilars might be a move it would make. Story | Follow @EricPFierce
@CarlyHFierce: ICYMI Friday: Positive H7N9 data could help Novartis hawk flu vax business. Article | Follow @CarlyHFierce
> Big Pharma aims to cast off old drugs to raise $42B for higher-profit R&D efforts. News
> Merck proposal to sell Singulair without a prescription hits resistance. Story
> Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains. More
CRO News
> Covance slips after narrowing its 2014 ambitions. Article
> Charles River ticks up revenue M&A on tap. More
> Quintiles keeps rolling with another $1B quarter. Report
> Parexel boosts revenue with eyes on a $1.9B year. Article
> Icon cranks up its 2014 expectations after another leap. Story
Biotech IT News
> Bina, SAS and others pitch new tools to boost biopharma R&D. Article
> Novartis steps up MS digital presence with iPhone app. Item
> Buzz: Google Ventures leading $100M round in oncology Big Data platform. More
> Canada to set up cancer cloud computing facility. News
> Medidata unveils Sanofi deal as it looks to recover from rocky April. Story